Streetbeat News

Regulatory

SPY

VGK

President Biden has stated that it is difficult to determine whether Russian President Putin has been weakened by recent events. The impact of these events on the US and European markets, represented by SPY and VGK respectively, is uncertain.

Portfolio Pulse from Happy Mohamed

June 28, 2023 | 1:37 pm

SPY

VGK

Ukraine's President Zelensky has expressed his desire for Ukraine to become a member of NATO after the war. This could potentially impact geopolitical relations and global markets.

Portfolio Pulse from Happy Mohamed

June 28, 2023 | 1:36 pm

SPY

VGK

Federal Reserve Chair Jerome Powell is presenting at the 'ECB Forum on Central Banking' on Wednesday, June 28. The ETFs SPY and VGK may be mentioned during the presentation.

Portfolio Pulse from Happy Mohamed

June 28, 2023 | 1:35 pm

MTC

MMTEC, Inc. (NASDAQ:MTC) has received a notification from Nasdaq regarding its failure to meet the minimum bid price requirements. The company's common stock was below $1.00 for 30 consecutive business days, which is against Nasdaq's Listing Rule 5550(a)(2). The notification has no immediate effect on the listing or trading of the company's common stock on the Nasdaq Capital Market.

Portfolio Pulse from Happy Mohamed

June 28, 2023 | 1:30 pm

CIR

KKR

Global investment firm KKR has reaffirmed its intention to acquire CIRCOR International, stating that the transaction maximizes shareholder value and minimizes regulatory, market, and industry risks. The transaction is expected to close in Q4 2023. KKR has also agreed to eliminate third party financing risk by providing a full equity backstop of the transaction. KKR's resources will help CIRCOR expand its presence in attractive flow control markets and support further investments into CIRCOR's factories.

Portfolio Pulse from Happy Mohamed

June 28, 2023 | 1:30 pm

SPY

VGK

Central bankers globally have increased interest rates to their highest levels in over a decade to combat inflation, but are uncertain if these measures are sufficient.

Portfolio Pulse from Happy Mohamed

June 28, 2023 | 1:24 pm

BAYRY

BAYZF

Bayer AG and its subsidiary BlueRock Therapeutics LP announced positive results from a Phase 1 trial of bemdaneprocel (BRT-DA01), a cell therapy for Parkinson's disease. The trial showed that bemdaneprocel was well-tolerated in all 12 patients, with no major safety events. The study also demonstrated the feasibility of transplantation and evidence of cell survival and engraftment in the brain through one year. A Phase 2 study is planned to begin enrolling patients in H1 2024.

Portfolio Pulse from Vandana Singh

June 28, 2023 | 1:20 pm

EXTR

A top manager at Extreme Networks has been privately selling high-tech in Russia, despite the company's announcement last year that it suspended all business activities in the country to show solidarity with Ukraine.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 1:17 pm

JOBY

Joby Aviation Inc (NYSE:JOBY) shares are trading higher after the company announced it received a permit to fly its first production aircraft. The company also appointed Tetsuo Ogawa, president and CEO of Toyota Motor North America, to its board. Toyota has invested $400 million in Joby over the last three years. Joby plans to begin commercial passenger operations in 2025.

Portfolio Pulse from Adam Eckert

June 28, 2023 | 1:06 pm

JOBY

Joby Aviation has received a permit allowing it to begin flight testing of its first production prototype, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 12:56 pm